[{"address1": "142 North Cedros Avenue", "address2": "Suite B", "city": "Solana Beach", "state": "CA", "zip": "92075", "country": "United States", "phone": "858 925 8215", "website": "https://effector.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "eFFECTOR Therapeutics, Inc., a biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer. The company's lead product candidates comprise Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer; and Zotatifin, a small molecule inhibitor of eukaryotic initiation factor 4A (eIF4E), which is in Phase 1/2 clinical trial to treat patients with solid tumors, as well as completed Phase 2a open-label expansion cohort in combination with fulvestrant and abemaciclib to treat patients with ER+ breast cancer. The company has a research collaboration and license agreement with Pfizer Inc. to research and develop small molecules that target eIF4E; and collaboration agreement with the Dana-Farber Cancer Institute on a Phase 2 clinical trial, evaluating Zotatifin as combination treatment in ER+ endometrial cancer and in low grade serous ovarian cancer. eFFECTOR Therapeutics, Inc. was incorporated in 2012 and is headquartered in Solana Beach, California.", "fullTimeEmployees": 14, "companyOfficers": [{"maxAge": 1, "name": "Mr. Craig R. Jalbert CIRA", "age": 62, "title": "CEO, President, Treasurer &Secretary, and Director", "yearBorn": 1962, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Davide  Ruggero Ph.D.", "title": "Co-Founder and Member of Clinical & Scientific Advisory Board", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kevan M. Shokat Ph.D.", "title": "Co-Founder and Member of Clinical & Scientific Advisory Board", "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.0003, "open": 0.0003, "dayLow": 0.0003, "dayHigh": 0.0003, "regularMarketPreviousClose": 0.0003, "regularMarketOpen": 0.0003, "regularMarketDayLow": 0.0003, "regularMarketDayHigh": 0.0003, "payoutRatio": 0.0, "beta": 0.217, "forwardPE": -0.00013333333, "volume": 350, "regularMarketVolume": 350, "averageVolume": 1678, "averageVolume10days": 676, "averageDailyVolume10Day": 676, "bid": 0.0251, "ask": 0.0349, "bidSize": 0, "askSize": 0, "marketCap": 1411, "fiftyTwoWeekLow": 0.0001, "fiftyTwoWeekHigh": 0.1, "fiftyDayAverage": 0.00027, "twoHundredDayAverage": 0.00266475, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -5133588, "profitMargins": 0.0, "floatShares": 4657224, "sharesOutstanding": 4704410, "sharesShort": 91617, "sharesShortPriorMonth": 110662, "sharesShortPreviousMonthDate": 1715731200, "dateShortInterest": 1718323200, "sharesPercentSharesOut": 0.0195, "heldPercentInsiders": 0.0291, "heldPercentInstitutions": 0.02628, "shortRatio": 0.97, "shortPercentOfFloat": 0.0197, "impliedSharesOutstanding": 4705000, "bookValue": 0.212, "priceToBook": 0.0014150945, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -34631000, "trailingEps": -12.57, "forwardEps": -2.25, "lastSplitFactor": "1:25", "lastSplitDate": 1705017600, "enterpriseToEbitda": 0.158, "52WeekChange": -0.99572647, "SandP52WeekChange": 0.12677538, "quoteType": "EQUITY", "currentPrice": 0.0003, "recommendationKey": "none", "totalCash": 25383000, "totalCashPerShare": 5.396, "ebitda": -32593000, "totalDebt": 20248000, "quickRatio": 0.993, "currentRatio": 1.027, "debtToEquity": 2448.368, "returnOnAssets": -0.83328, "grossProfits": -21616000, "freeCashflow": -17665876, "operatingCashflow": -29191000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "EFTR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "eFFECTOR Therapeutics, Inc.", "longName": "eFFECTOR Therapeutics, Inc.", "exchange": "NGM", "messageBoardId": "finmb_240590335", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.0003, "corporateActions": [], "regularMarketTime": 1751385396, "epsTrailingTwelveMonths": -12.57, "epsForward": -2.25, "fiftyDayAverageChange": 3.0000025e-05, "fiftyDayAverageChangePercent": 0.11111121, "twoHundredDayAverageChange": -0.00236475, "twoHundredDayAverageChangePercent": -0.8874191, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1678, "fiftyTwoWeekLowChange": 0.00020000001, "fiftyTwoWeekLowChangePercent": 2.0000002, "fiftyTwoWeekRange": "1.0E-4 - 0.1", "fiftyTwoWeekHighChange": -0.099700004, "fiftyTwoWeekHighChangePercent": -0.99700004, "fiftyTwoWeekChangePercent": -99.57265, "earningsTimestampStart": 1753700340, "earningsTimestampEnd": 1754568000, "isEarningsDateEstimate": true, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1630071000000, "regularMarketChange": 0.0, "regularMarketDayRange": "3.0E-4 - 3.0E-4", "displayName": "eFFECTOR Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-07-05"}]